期刊文献+

MGMT基因启动子甲基化与MGMT蛋白和NF-κB在脑胶质瘤的表达及意义 被引量:5

The significance of MGMT promoter methylation and the expression of MGMT and NF-κB in glioma
原文传递
导出
摘要 目的探讨MGMT和NF-κB在脑胶质瘤中的表达及两者的相关性和MGMT基因启动子甲基化与其蛋白表达的相关性分析。方法采用免疫组化EnVision法检测MGMT和NF-κB在42例不同级别脑胶质瘤石蜡标本中的表达,运用MSP方法检测MGMT基因启动子甲基化状况。结果 (1)MGMT在低级别组胶质瘤中的表达率为73.7%;在高级别组中其表达率为21.7%。(2)NF-κB在低级别组胶质瘤中的表达率为52.6%,在高级别组中的表达率为60.9%。(3)42例胶质瘤中MGMT基因启动子甲基化发生率为50%,其中MGMT蛋白阳性的胶质瘤,启动子甲基化发生率为26.3%;MGMT蛋白表达阴性的胶质瘤,启动子甲基化发生率为69.6%;MGMT蛋白表达阳性率与其基因启动子甲基化呈负相关。(4)MGMT与NF-κB两者表达无相关性。结论 MGMT蛋白表达随胶质瘤的级别增高而下降,NF-κB与MGMT与胶质瘤级别无相关性。 Objective To investigate the expression of MGMT and NF-KB in glioma and correlation between MGMT and NF-κB,MGMT gene promoter methylation and its protein expression. Methods Immunohistochemistry assay was conducted to detect the expression of MGMT and NF-KB in gliomas;methylation specific PCR( MSP)was used to analyze the MGMT promoter methylation in glioma. Results ( 1 ) The ratio of MGMT expression was 73.7% in the low grade group glioma; its expression was 21.7% in the high grade group. (2)NF-KB expression rate was 52. 6% in the low grade group glioma,expression of the high grade group was 60.9%. (3)In the 42 cases,the level of MGMT promoter methylalon was 50% ;it was in 19 cases that MGMT protein expresses positively, and among which 5 cases were methylated, so the positive expression rate was 26.3%. MGMT protein expression had negative correlation with its promoter methylation. (4) There was no correlation between MGMT and NF-KB expressions. Conclusions MGMT expression decrease following the level of glioma rise and there is no correlation comparison the expression of NF-KB, and MGMT with glioma level.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第4期68-70,共3页 Chinese Journal of Clinicians(Electronic Edition)
基金 国家自然科学基金(81060191) 云南省自然科学基金(2009CD091)
关键词 神经胶质瘤 O(6)-甲基鸟嘌呤DNA甲基转移酶 NF-ΚB 甲基化 Glioma O(6)-methylguanine-DNA methyltransferase NF-kappa B Methylation
  • 相关文献

参考文献1

二级参考文献1

共引文献4

同被引文献37

  • 1Abdel-Rahman N. Zekri,Gelane M. Sabry,Abeer A. Bahnassy,Kamal A. Shalaby,Sabrin A.Abdel-Wahabh,Serag Zakaria.Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6,HMSH2) in the pathogenesis of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(20):3020-3026. 被引量:10
  • 2HARGRAVE D R, ZACHAROULIS S. Pediatric CNS tumors: current treat - ment and future directions [J]. Expert Rev Neuro- ther, 2007, 7(8): 1029- 1042.
  • 3STUPP R, HEGI M E, MASON W P, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapyalone on survival in glioblastoma in a randomised phase Ill study 5 - year analysis of the EORT C -NCIC trial[ J]. Lancet Oncol, 2009, 10(5) : 459 -466.
  • 4SARISSKY M, LAVICKA J, KOCANOVA S, et al. Diazepam en- hances hypericin - induced photocytotoxicity and apoptosis in hmnan glioblas - toma cells [J].Neoplasma, 2005, 52 (4) : 352 - 359.
  • 5HULSEBOS T J, TROOST D, LEENSTRA S. Molecular - genetic characterization of gliomas that recur as same grade or higher grade tumours [ J ]. J Neurol Neurosurg Psychiatry, 2004, 75 ( 5 ) : 723 - 726.
  • 6HOANG XUAN K, IDBAIH A, MOKHARI K, et al. Towards a molecular classification of gliomas [J]. Bull Cancer, 2005, 92 (4) : 310 -314.
  • 7ZHEN Y D, LIN Z, YONG M L, et al. The safety and efficacy of paelitaxel ]iposome for elderly patients with advanced non - small cell lung cancer: a multi -center prospective study [ J]. J Thorae Cancer, 2013, 21(1) : 14 - 19.
  • 8LOUIS D N, OHGAKI H, WIESTLER O D, et al. WHO classifi- cation of tumours of the central nervous system [ J]. Aeta Neuro- pathol, 2007, 114(2) : 97 - 109.
  • 9Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core path- ways[J]. Nature, 2008, 455(7216): 1061-1068.
  • 10HEIMBERGER A B, SAMPSON J H. The PEPvIII - KLH( CDX - 110) vaccine in glioblastoma multiforme patients[J]. Expert Opin Ther. 2009. 9(8): 1087-1098.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部